Key result
Minimally invasive port-access mitral valve replacement in dogs yields excellent recovery of LV function.
Why the study?
Does minimally invasive port-access mitral valve replacement preserve myocardial function in a canine model?
Does minimally invasive port-access mitral valve replacement preserve myocardial function in a canine model?
Minimally invasive port-access mitral valve replacement is technically feasible and preserves myocardial function in a canine model, supporting the initiation of clinical trials.
Answers are grounded in this paper and cite their sources.
Supports myocardial preservation in canine port-access MVR; leaves open translation to human clinical practice.
OBJECTIVE: This experiment examined the feasibility of minimally invasive port-access mitral valve replacement via a 2.5 cm incision. METHODS: The study evaluated valvular performance and myocardial functional recovery in six mongrel dogs after port-access mitral valve replacement with a St. Jude Medical prosthesis (St. Jude Medical, Inc., St. Paul, Minn.). Femoro-femoral cardiopulmonary bypass and a balloon catheter system for myocardial protection with cardioplegic arrest (Heartport, Inc., Redwood City, Calif.) were used. The mitral valve was replaced through a 2.5 cm port in the left side of the chest, and the animals were weaned from bypass. Cardiac function was measured before and at 30 and 60 minutes after bypass. Left ventricular pressure and electrical conductance volume were used to calculate changes in load-independent indexes of ventricular function. RESULTS: Each procedure was successfully completed. Recovery of left ventricular function was excellent at 30 and 60 minutes after bypass compared with the prebypass values for elastance (30 minutes = 4.04 +/- 0.97 and 60 minutes = 4.27 +/- 0.57 vs prebypass = 4.45 +/- 0.96; p = 0.51) and for preload recruitable stroke work (30 minutes = 76.23 +/- 4.80 and 60 minutes = 71.21 +/- 2.99 vs prebypass = 71.23 +/- 3.75; p = 0.45). Preload recruitable work area remained at 96% and 85% of baseline at 30 and 60 minutes (p = not significant). In addition, transesophageal echocardiography demonstrated normal prosthetic valve function, as well as normal regional and global ventricular wall motion. Autopsy revealed secure annular-sewing apposition and normal leaflet motion. CONCLUSIONS: These results suggest that minimally invasive mitral valve replacement using percutaneous cardiopulmonary bypass with cardioplegic arrest is technically reproducible, achieves normal valve placement, and results in complete cardiac functional recovery. Minimally invasive mitral valve replacement is now feasible, and clinical trials are indicated.
No takes yet. Share an insight, caveat, or question.
Schwartz et al. (1997) studied Mitral valve replacement (experimental model) (n=6). Minimally invasive port-access mitral valve replacement vs. Prebypass baseline was evaluated on Recovery of left ventricular function (elastance) (p=0.51). Minimally invasive port-access mitral valve replacement in dogs resulted in excellent recovery of left ventricular function at 60 minutes compared to prebypass baseline.
Synapse has enriched 10 related papers. Consider them for comparative context: